ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PRM Proteome Sciences Plc

4.05
0.19 (4.92%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.19 4.92% 4.05 3.30 4.80 - 72,225 16:35:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 7.78M 1.33M 0.0045 8.58 11.39M
Proteome Sciences Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 3.86p. Over the last year, Proteome Sciences shares have traded in a share price range of 2.97p to 8.50p.

Proteome Sciences currently has 295,182,056 shares in issue. The market capitalisation of Proteome Sciences is £11.39 million. Proteome Sciences has a price to earnings ratio (PE ratio) of 8.58.

Proteome Sciences Share Discussion Threads

Showing 152451 to 152474 of 157575 messages
Chat Pages: Latest  6099  6098  6097  6096  6095  6094  6093  6092  6091  6090  6089  6088  Older
DateSubjectAuthorDiscuss
01/4/2021
11:40
Jeffian
Looks like you have some Qs for the Q&A

Re costs, bear in mind that TMT Pro, the and work on new tryptophan and AD assays did add to costs, but were scaled back, although I forget when


Does your lack of explaining what you felt was incorrect in my earlier post mean that you now see you were mistaken Jeffers? Not like you to miss the opportunity to prove someone wrong

stocktastic
01/4/2021
11:36
BOL!

What a silly billy.

tom barnaby
01/4/2021
11:31
Some made-up nonsense about the test already being sold to customers.
monte1
01/4/2021
11:28
I note that Randox_Richard has edited the post.

What did the original 'say'?

tom barnaby
01/4/2021
11:23
Good point and very well made imco.

C’mon the PRM

monte1
01/4/2021
11:21
#88766,

Well indeed they did at the time, pools2, and I think I even mentioned £10m when their overheads were running at a "stable" £5m/year. The point is that all the improvement at the moment is down to cost-cutting, not a huge improvement in revenues or profitability.

jeffian
01/4/2021
11:17
Once more pools2 - this time in English please.

tia

Edit - translated version now noted.

monte1
01/4/2021
11:16
Coming from our self professed expert who was telling us a short while ago that PRM needed £6.5 million revenue just to break even.
pools2
01/4/2021
11:11
Well it's hard to fathom what is going on but at the heart of it we have a company which is less profitable at the operating level but has generated cash and a better bottom line by slashing administrative costs in an inexplicable way.

The huge improvement in the second half comes entirely from the massive drop in Administrative Expenses (a mere £654k apparently against previous half-years when it has been running at c.£1.2-£1.3m). I'm also interested to note that they show total Administrative expenses for the year down to £2.036m and yet staff costs alone are £2.15m. How does that work?

There is a blurring of Operating and Administrative costs into 'total costs' but the plain fact is that the Gross Profit margin has remained pretty constant for years around 55% producing a GP this year of £550k to run the business. Hmmmm.

jeffian
01/4/2021
11:06
This co is now profitable with a decent outlook over next 3-5yrs.
A good place to be IMO.
W41

wrighty41
01/4/2021
10:41
Ah well, we didn't get to where we are today by over-delivering ...
small crow
01/4/2021
10:40
Lol If we hadn't hired the above CEO. we would have had £500,000 profit.
madmick
01/4/2021
10:17
Good morning Randhoax_Girl
monte1
01/4/2021
10:14
Investor Presentation

Proteome Sciences PLC is pleased to announce that Chief Executive Officer, Dr Mariola Soehngen, will provide a live presentation relating to the Company's results for the year ended 31 December 2020 via the Investor Meet Company platform on Thursday, 8 April 2021 at 10.00am BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and select to meet Proteome Sciences PLC via:

Investors who already follow Proteome Sciences PLC on the Investor Meet Company platform will automatically be invited.

elpirata
01/4/2021
09:37
Slightly underwhelmed by the results
the bull
01/4/2021
09:36
Why doesn't PRM tell us about their recent Ck1d therapeutic patent grant on 27th October last year in their final results for 2020 today ???





Answers on a postcard please

wasjobber
01/4/2021
09:31
goatherd 29 Mar '21 - 18:35 - 58753 of 58789
0 4 0
I have a suspicion (entirely without evidence) that the demand could be coming from the Randox side as I am expecting their CE anytime

BOL!

elpirata
01/4/2021
09:30
quite right monte1, I note the re-rating is in play
elpirata
01/4/2021
09:05
They are not having mine cheap.
monte1
01/4/2021
09:02
Now they are going to bore you out of your shares
mashman
01/4/2021
09:00
As you were!!!!.
peverill
01/4/2021
08:39
I note that the increase in cash was primarily due to a significant Prepayment and 'managing' creditors.
tom barnaby
01/4/2021
08:37
A little bit more than expected ten times more!
csmwssk12hu
01/4/2021
08:35
How veerrry dare you.
monte1
Chat Pages: Latest  6099  6098  6097  6096  6095  6094  6093  6092  6091  6090  6089  6088  Older